论文信息 - TP53 Mutations and Outcome After Fludarabine and Cyclophosphamide (FC) or FC Plus Rituximab (FCR) in the CLL8 Trial of the GCLLSG. - 字舞流文

TP53 Mutations and Outcome After Fludarabine and Cyclophosphamide (FC) or FC Plus Rituximab (FCR) in the CLL8 Trial of the GCLLSG.

H. Döhner | U. Jäger | M. Hallek | S. Stilgenbauer | T. Zenz | D. Winkler | A. Bühler | M. Kneba | M. Mendila | S. Böttcher | R. Busch | A. Fink | K. Fischer | M. Wenger | Lin Wu | N. Patten | S. Truong | P. Hoth | H. Helfrich | G. Fingerle-Rowson | Patrick Hoth